<DOC>
	<DOC>NCT00275912</DOC>
	<brief_summary>This study is aimed to collect additional data regarding the efficacy in reducing the frequency of partial seizures, as well as the safety and tolerability, of oxcarbazepine monotherapy in children.</brief_summary>
	<brief_title>Efficacy, Safety, and Tolerability of Oxcarbazepine Monotherapy in Children With Partial Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsies, Partial</mesh_term>
	<mesh_term>Oxcarbazepine</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<criteria>males and females, 6 months 17 years of age; diagnosis of epilepsy, partial seizures; ineffective or intolerable present therapy with 1 antiepileptic drug, or none of previous antiepileptic therapy progressive lesion of brain revealed by CT/MRI that performed no earlier than 2 years prior to screening; nonepileptic seizures; drug or alcohol dependence during a year prior to screening; Other protocoldefined inclusion/exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>